Hypoxemia vs. Hypercapnia - Pathophysiology

SECTION 1

Historical Context & Motivation

The ability to distinguish between inadequate oxygen delivery and excessive carbon dioxide retention in the blood has been central to the evolution of respiratory medicine. Before clinicians could measure arterial blood gases, respiratory failure was a poorly differentiated syndrome — patients were described simply as "asphyxiated" or "cyanotic" without a clear understanding of the underlying chemical derangement. The modern distinction between hypoxemia (low arterial PaO₂) and hypercapnia (elevated arterial PaCO₂) arose from centuries of painstaking work in gas chemistry, pulmonary physiology, and clinical measurement technology. Understanding this history illuminates why these two conditions demand different therapeutic strategies and why conflating them can be clinically dangerous.

1774 • Discovery of Oxygen

Joseph Priestley isolated "dephlogisticated air" (oxygen), and Antoine Lavoisier subsequently named it, establishing that respiration is a form of slow combustion requiring this gas to sustain life.

1856 • Blood Gas Measurement Begins

Carl Ludwig and colleagues developed the blood gas manometer, enabling the first quantitative measurements of dissolved O₂ and CO₂ in arterial and venous blood and establishing that gas exchange occurs across the pulmonary membrane.

1904 • The Bohr Effect Described

Christian Bohr published his landmark work demonstrating that CO₂ and pH influence hemoglobin's affinity for O₂, revealing the intimate coupling between oxygen transport and carbon dioxide levels in the blood.

1952 • Copenhagen Polio Epidemic

Bjørn Ibsen pioneered positive-pressure ventilation to treat bulbar poliomyelitis, demonstrating that mechanical ventilation could correct both hypoxemia and hypercapnia — a watershed moment for modern intensive care medicine.

1958 • Severinghaus Electrode

John Severinghaus and A. Freeman Bradley developed the PaCO₂ electrode, completing the modern arterial blood gas (ABG) analyzer and enabling rapid bedside differentiation of hypoxemic versus hypercapnic respiratory failure.

The central question this lesson addresses is deceptively straightforward: What distinguishes a failure of oxygenation from a failure of ventilation, and why does the distinction matter clinically? As we will see, hypoxemia and hypercapnia arise through overlapping but fundamentally different pathophysiological mechanisms, they trigger distinct compensatory responses, and they require targeted interventions. Mastering this distinction is essential for every healthcare professional who interprets arterial blood gases or manages patients in respiratory distress.

SECTION 2

Core Principles & Definitions

At its core, the distinction between hypoxemia and hypercapnia maps onto two different aspects of pulmonary function. Oxygenation refers to the transfer of oxygen from alveolar gas into pulmonary capillary blood, while ventilation refers to the bulk movement of gas into and out of the alveoli, which is primarily responsible for eliminating CO₂. Hypoxemia is defined as a PaO₂ below 80 mmHg on room air at sea level (with severe hypoxemia generally classified as PaO₂ < 60 mmHg), whereas hypercapnia is defined as a PaCO₂ exceeding 45 mmHg. Although these two derangements frequently coexist, they can occur independently, and their clinical management diverges considerably.

Hypoxemia

A reduction in arterial oxygen tension (PaO₂ < 80 mmHg). Reflects a failure of oxygenation — the lung's ability to load O₂ onto hemoglobin across the alveolar-capillary membrane.

Hypercapnia

An elevation in arterial carbon dioxide tension (PaCO₂ > 45 mmHg). Reflects a failure of ventilation — the lung's ability to eliminate CO₂ through adequate alveolar minute ventilation.

Type I Respiratory Failure

Hypoxemic failure without CO₂ retention. PaO₂ is low, but PaCO₂ is normal or low (due to compensatory hyperventilation). Classic causes include pneumonia, ARDS, and pulmonary embolism.

Type II Respiratory Failure

Hypercapnic (ventilatory) failure. PaCO₂ is elevated, and PaO₂ is typically also reduced. Classic causes include COPD exacerbation, neuromuscular weakness, and severe obesity hypoventilation syndrome.

A-a Gradient

The alveolar–arterial oxygen gradient quantifies the efficiency of gas exchange. A normal A-a gradient with hypoxemia suggests hypoventilation or low FiO₂; a widened gradient points to V/Q mismatch, shunt, or diffusion impairment.

✦

KEY TAKEAWAY

Think of the lung as a factory with two assembly lines. The oxygenation line brings in raw material (O₂) and loads it onto delivery trucks (hemoglobin). The ventilation line removes waste product (CO₂) from the building. A problem on the loading dock (V/Q mismatch, shunt) mainly stalls O₂ delivery — that is hypoxemia. A problem with the exhaust fans (reduced minute ventilation) traps waste CO₂ inside — that is hypercapnia. Both lines share the same building, so a severe malfunction can affect both, but the root causes and the fixes are different.

SECTION 3

Visual Explanation — Gas Exchange at the Alveolar-Capillary Unit

Three panels compare gas exchange at the alveolar-capillary unit. Left: Normal exchange yields PaO₂ ≈ 95 mmHg and PaCO₂ ≈ 40 mmHg. Center: In Type I failure (hypoxemia), V/Q mismatch or shunt impairs O₂ transfer but compensatory hyperventilation keeps PaCO₂ normal or low; the A-a gradient widens. Right: In Type II failure (hypercapnia), reduced alveolar ventilation causes CO₂ retention and secondary hypoxemia; the A-a gradient may remain normal if the lung parenchyma is intact.

As illustrated above, the key diagnostic clue lies in the A-a gradient. In pure hypoventilation (e.g., opioid overdose depressing the respiratory center), the alveolar-capillary membrane functions normally — both O₂ and CO₂ partial pressures shift together, and the A-a gradient remains within the expected range of 5–15 mmHg for a young adult. In contrast, when a parenchymal process such as pneumonia or ARDS disrupts ventilation–perfusion matching, the A-a gradient widens because well-ventilated units cannot fully compensate for the venous admixture from poorly ventilated or shunted units. This distinction is critical: supplemental oxygen readily corrects the hypoxemia of hypoventilation but may have little effect on a large intrapulmonary shunt, which requires positive-pressure ventilation or treatment of the underlying pathology.

SECTION 4

Mathematical Framework — Key Equations

Several quantitative relationships underpin the clinical assessment of oxygenation and ventilation. Understanding these equations allows clinicians to calculate expected values, identify abnormalities, and predict the response to therapeutic interventions.

ALVEOLAR GAS EQUATION

PAO₂ = FiO₂ × (Pᴮ − PH₂O) − (PaCO₂ / R)

PAO₂ = alveolar partial pressure of O₂; FiO₂ = fraction of inspired oxygen (0.21 on room air); Pᴮ = barometric pressure (760 mmHg at sea level); PH₂O = water vapor pressure (47 mmHg at 37 °C); PaCO₂ = arterial CO₂ tension; R = respiratory exchange ratio (≈ 0.8). This equation is the foundation for calculating the A-a gradient.

A-a GRADIENT

A-a gradient = PAO₂ − PaO₂

A normal A-a gradient is approximately 5–15 mmHg in a young adult breathing room air. The expected normal value increases with age and can be estimated as: Expected A-a ≈ (Age / 4) + 4. A widened gradient indicates a parenchymal or vascular cause of hypoxemia (V/Q mismatch, shunt, or diffusion limitation).

ALVEOLAR VENTILATION EQUATION

PaCO₂ = (V̇CO₂ × 0.863) / V̇A

V̇CO₂ = CO₂ production (mL/min); V̇A = alveolar ventilation (L/min); 0.863 is a conversion constant for BTPS to STPD. This equation demonstrates the inverse relationship between alveolar ventilation and PaCO₂: halving V̇A doubles PaCO₂.

MINUTE VENTILATION & DEAD SPACE

V̇A = (VT − VD) × f

VT = tidal volume; VD = anatomical + alveolar dead space volume; f = respiratory rate. Total minute ventilation (V̇E = VT × f) exceeds alveolar ventilation because dead space receives ventilation but does not participate in gas exchange. Increased dead space (e.g., pulmonary embolism) reduces effective V̇A and promotes hypercapnia unless compensatory increases in VT or f occur.

💡

Clinical Pearl

Remember that PaCO₂ is inversely proportional to alveolar ventilation. A patient who doubles their alveolar ventilation will halve their PaCO₂. Conversely, supplemental O₂ can correct PaO₂ without necessarily fixing PaCO₂ — this is why patients with COPD may develop worsening hypercapnia when given excessive oxygen if their hypoxic ventilatory drive is blunted.

SECTION 5

Mechanisms of Hypoxemia & Hypercapnia — A Detailed Breakdown

Hypoxemia arises through five principal mechanisms, each with a characteristic response to supplemental oxygen and a distinguishing A-a gradient pattern. Hypercapnia, in contrast, ultimately reflects inadequate alveolar ventilation relative to CO₂ production, though several upstream pathologies can produce this final common pathway. The following diagram and table systematically categorize these mechanisms.

Flowchart categorizing hypoxemia by A-a gradient (normal = hypoventilation or low FiO₂; widened = V/Q mismatch, shunt, or diffusion impairment) and hypercapnia by mechanism (decreased central drive, neuromuscular pump failure, or increased dead space/CO₂ production). The lower-left box summarizes O₂ responsiveness: true shunt is refractory to supplemental oxygen alone.

Mechanism	Primary Defect	A-a Gradient	Response to O₂	Example
Low FiO₂	Reduced inspired O₂ (↓PiO₂)	Normal	Excellent	High altitude
Hypoventilation	↓V̇A → ↑PaCO₂ → ↓PAO₂	Normal	Good (but does not fix CO₂)	Opioid OD, obesity hypoventilation
V/Q Mismatch	Uneven distribution of ventilation relative to perfusion	Widened	Good to moderate	COPD, asthma, pneumonia
Right-to-Left Shunt	Blood bypasses ventilated alveoli entirely	Widened	Poor (refractory)	ARDS, atelectasis, ASD/VSD
Diffusion Impairment	Thickened or destroyed alveolar-capillary membrane	Widened (esp. with exercise)	Good at rest	IPF, emphysema

Five mechanisms of hypoxemia with diagnostic features

Hypercapnia can be conceptualized as an imbalance between CO₂ production and alveolar ventilation. The three broad upstream categories are: decreased central respiratory drive (e.g., brainstem pathology, sedation), neuromuscular or chest wall pump failure (e.g., Guillain-Barré syndrome, myasthenia gravis, severe kyphoscoliosis), and increased dead space or CO₂ production (e.g., pulmonary embolism increasing dead space, fever and sepsis increasing metabolic CO₂ output). In the clinical setting, these mechanisms often overlap — for instance, a patient with severe COPD may have both V/Q mismatch causing hypoxemia and increased dead space causing hypercapnia, plus respiratory muscle fatigue contributing to reduced tidal volumes.

SECTION 6

Worked Example — Interpreting an ABG

A 62-year-old man with a history of COPD presents to the emergency department with worsening dyspnea over two days. He is on room air (FiO₂ = 0.21). His arterial blood gas results are: pH 7.32, PaO₂ 52 mmHg, PaCO₂ 58 mmHg, HCO₃⁻ 30 mEq/L. Determine whether this patient has hypoxemia, hypercapnia, or both, and calculate the A-a gradient to identify the mechanism.

ABG Interpretation in COPD Exacerbation

1
Step 1 — Identify the Given Values

FiO₂ = 0.21 (room air); Pᴮ = 760 mmHg (sea level assumed); PH₂O = 47 mmHg; PaCO₂ = 58 mmHg; PaO₂ = 52 mmHg; R = 0.8 (standard respiratory quotient). The pH of 7.32 with an elevated HCO₃⁻ of 30 mEq/L suggests partially compensated respiratory acidosis.
2
Step 2 — Determine Hypoxemia and Hypercapnia Status

PaO₂ = 52 mmHg, which is below the threshold of 80 mmHg and even below 60 mmHg — this qualifies as severe hypoxemia. PaCO₂ = 58 mmHg, which exceeds the upper limit of 45 mmHg — this qualifies as hypercapnia. The patient has Type II (hypercapnic) respiratory failure with coexisting hypoxemia.

Both hypoxemia and hypercapnia are present → Type II respiratory failure
3
Step 3 — Calculate PAO₂ Using the Alveolar Gas Equation

PAO₂ = FiO₂ × (Pᴮ − PH₂O) − (PaCO₂ / R) = 0.21 × (760 − 47) − (58 / 0.8) = 0.21 × 713 − 72.5 = 149.7 − 72.5 = 77.2 mmHg. Note how the elevated PaCO₂ substantially reduces the calculated alveolar PO₂ compared to the normal value of ≈100 mmHg.

PAO₂ ≈ 77 mmHg
4
Step 4 — Calculate the A-a Gradient

A-a gradient = PAO₂ − PaO₂ = 77 − 52 = 25 mmHg. The expected A-a gradient for a 62-year-old is approximately (62 / 4) + 4 = 19.5 mmHg. Since 25 mmHg exceeds the expected value, the gradient is mildly widened.

A-a gradient = 25 mmHg (widened)
5
Step 5 — Interpret the Mechanism

The widened A-a gradient indicates that the hypoxemia is not solely due to hypoventilation. If pure hypoventilation were the only mechanism, the A-a gradient would remain normal despite the elevated PaCO₂. The widened gradient points to a concomitant parenchymal process — in this COPD patient, V/Q mismatch due to airway obstruction and hyperinflation is the most likely additional mechanism. The elevated HCO₃⁻ of 30 mEq/L with only partial pH compensation suggests this is an acute exacerbation superimposed on chronic hypercapnia. Management should include controlled oxygen therapy (target SpO₂ 88–92%), bronchodilators, and consideration of non-invasive positive-pressure ventilation if CO₂ continues to rise.

Mixed mechanism: hypoventilation + V/Q mismatch in COPD exacerbation

SECTION 7

Clinical Features — Hypoxemia vs. Hypercapnia Side by Side

Although hypoxemia and hypercapnia frequently coexist, each produces a distinct constellation of signs and symptoms because they affect different physiological pathways. Hypoxemia primarily threatens aerobic metabolism and triggers sympathetic activation, whereas hypercapnia acts as a vasodilator and central nervous system depressant when severe. Recognizing these clinical patterns at the bedside can guide initial management even before ABG results are available.

Feature	Hypoxemia	Hypercapnia
Definition	PaO₂ < 80 mmHg (severe: < 60 mmHg)	PaCO₂ > 45 mmHg
Primary physiological defect	Failure of oxygenation across alveolar-capillary membrane	Failure of ventilation (CO₂ elimination)
Cardiovascular signs	Tachycardia, hypertension (early), hypotension and bradycardia (late/severe)	Bounding pulse, peripheral vasodilation, warm extremities, headache
Neurological signs	Restlessness, confusion, seizures, loss of consciousness	Drowsiness, flapping tremor (asterixis), CO₂ narcosis, papilledema
Respiratory pattern	Tachypnea, use of accessory muscles, intercostal retractions	Variable: may be tachypneic early, but shallow breathing or apnea if drive is impaired
Skin appearance	Central cyanosis (when SaO₂ < ~85%)	Flushed, diaphoretic (CO₂-mediated vasodilation)
Acid-base effect	Lactic acidosis if tissue hypoxia ensues	Respiratory acidosis (↓pH); renal compensation raises HCO₃⁻ over days
Pulse oximetry utility	SpO₂ directly reflects severity	SpO₂ may be normal if supplemental O₂ is given — cannot detect hypercapnia
Key management	Supplemental O₂, PEEP/CPAP, treat underlying cause	Increase V̇A: NIV (BiPAP), mechanical ventilation, reverse sedation, treat cause

Clinical comparison of hypoxemia and hypercapnia

✦

KEY TAKEAWAY

A critical bedside pitfall is relying solely on pulse oximetry. SpO₂ measures oxygen saturation and will detect hypoxemia, but it tells you nothing about CO₂. A patient on supplemental oxygen may have a normal SpO₂ of 97% while silently accumulating CO₂ to dangerous levels. This is why arterial blood gas analysis remains the gold standard for detecting hypercapnia. End-tidal CO₂ (capnography) offers a non-invasive surrogate but is less accurate in patients with significant dead space.

SECTION 8

Connection to Advanced Respiratory Physiology

The foundational concepts of hypoxemia and hypercapnia connect directly to several advanced topics in respiratory and critical care medicine. Understanding these bridges prepares students for deeper study of mechanical ventilation, permissive hypercapnia strategies, and the pathophysiology of complex conditions such as acute respiratory distress syndrome (ARDS) and chronic respiratory failure.

Foundational Concept	Advanced Extension	Clinical Relevance
A-a gradient distinguishes oxygenation vs. ventilation failure	PaO₂/FiO₂ (P/F) ratio — standardized index of oxygenation severity used in Berlin ARDS criteria	P/F < 300 = mild ARDS; < 200 = moderate; < 100 = severe. Guides ventilator strategy and prone positioning decisions.
PaCO₂ inversely proportional to V̇A	Permissive hypercapnia — deliberate acceptance of elevated PaCO₂ to allow lung-protective ventilation with low tidal volumes	In ARDS, limiting VT to 6 mL/kg ideal body weight reduces ventilator-induced lung injury (VILI) even though PaCO₂ may rise to 50–70 mmHg.
True shunt is refractory to supplemental O₂	Shunt equation (Qs/Qt) — quantifies the fraction of cardiac output bypassing ventilated alveoli	Used to determine if PEEP recruitment, prone positioning, or ECMO is indicated for refractory hypoxemia.
Chronic hypercapnia triggers renal HCO₃⁻ retention	Oxygen-induced hypercapnia — excessive O₂ in chronic CO₂ retainers worsens hypercapnia via Haldane effect, loss of hypoxic vasoconstriction, and blunted ventilatory drive	Guides controlled oxygen therapy in COPD: target SpO₂ 88–92% with Venturi mask to avoid precipitating acute-on-chronic hypercapnic failure.

Connections between foundational and advanced respiratory concepts

Looking ahead, the principles discussed in this lesson form the physiological backbone for understanding mechanical ventilation modes (volume-controlled vs. pressure-controlled), the rationale behind positive end-expiratory pressure (PEEP), and the indications for extracorporeal membrane oxygenation (ECMO). In each of these advanced therapeutic modalities, the clinician's fundamental task remains the same: optimizing oxygenation to ensure adequate tissue O₂ delivery while maintaining ventilation sufficient to prevent dangerous CO₂ accumulation — or, in the case of permissive hypercapnia, deliberately tolerating a controlled degree of CO₂ elevation to protect the lungs from barotrauma and volutrauma.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A patient has a PaO₂ of 55 mmHg and a PaCO₂ of 32 mmHg while breathing room air. Does this patient have hypoxemia, hypercapnia, both, or neither? What type of respiratory failure does this pattern represent, and why is the PaCO₂ low rather than elevated?

Show answer

This patient has hypoxemia (PaO₂ < 80 mmHg) without hypercapnia — in fact, the PaCO₂ of 32 mmHg indicates hypocapnia. This is the hallmark of Type I (hypoxemic) respiratory failure. The low PaCO₂ results from compensatory hyperventilation driven by peripheral chemoreceptor stimulation: the carotid bodies detect low PaO₂ and increase respiratory drive, causing the patient to blow off more CO₂ than normal. This compensatory mechanism is intact precisely because the respiratory pump (chest wall, muscles, brainstem drive) is functioning — the problem lies at the level of gas exchange (e.g., V/Q mismatch or shunt), not ventilation.

Question 2: BASIC CALCULATION

Calculate the A-a gradient for a 40-year-old patient breathing room air (FiO₂ = 0.21) at sea level with a PaO₂ of 70 mmHg and a PaCO₂ of 40 mmHg. Use R = 0.8. Is the gradient normal or widened for this patient's age?

Show answer

First, calculate PAO₂ using the alveolar gas equation: PAO₂ = 0.21 × (760 − 47) − (40 / 0.8) = 0.21 × 713 − 50 = 149.7 − 50 = 99.7 mmHg. Then, A-a gradient = PAO₂ − PaO₂ = 99.7 − 70 = 29.7 mmHg. The expected A-a gradient for a 40-year-old is approximately (40 / 4) + 4 = 14 mmHg. Since 29.7 mmHg significantly exceeds 14 mmHg, the gradient is widened, indicating a parenchymal or vascular cause of hypoxemia such as V/Q mismatch, shunt, or diffusion impairment — not simple hypoventilation.

Question 3: INTERMEDIATE

A patient with Guillain-Barré syndrome has a PaO₂ of 65 mmHg and a PaCO₂ of 62 mmHg on room air. Calculate the A-a gradient (R = 0.8). Explain why the A-a gradient helps distinguish this patient's hypoxemia from that of a patient with pneumonia who has a similar PaO₂.

Show answer

PAO₂ = 0.21 × (760 − 47) − (62 / 0.8) = 149.7 − 77.5 = 72.2 mmHg. A-a gradient = 72.2 − 65 = 7.2 mmHg. This is a normal A-a gradient, which tells us the alveolar-capillary membrane is intact. The hypoxemia is entirely explained by the elevated PaCO₂ — as CO₂ accumulates in the alveolus (due to neuromuscular weakness reducing tidal volume), it displaces O₂, lowering PAO₂ and consequently PaO₂. In contrast, a pneumonia patient with PaO₂ of 65 mmHg and a normal or low PaCO₂ would have a widened A-a gradient because consolidation causes V/Q mismatch or shunt. The A-a gradient therefore helps clinicians identify the underlying mechanism: normal gradient points toward hypoventilation as the sole cause, while a widened gradient implicates intrinsic lung pathology.

Question 4: APPLIED

A 70-year-old patient with severe COPD is brought to the ED. On room air: pH 7.28, PaO₂ 48 mmHg, PaCO₂ 72 mmHg, HCO₃⁻ 33 mEq/L. The nurse places the patient on a non-rebreather mask at 15 L/min O₂. Thirty minutes later, the SpO₂ has improved to 100%, but the patient is now increasingly somnolent. What is the most likely explanation for the clinical deterioration, and what would be a more appropriate oxygen delivery strategy?

Show answer

The elevated baseline HCO₃⁻ of 33 mEq/L indicates chronic CO₂ retention with renal compensation, consistent with longstanding COPD. In such patients, the normal hypercapnic ventilatory drive (mediated by central chemoreceptors) is chronically blunted, and the primary stimulus to breathe becomes the hypoxic ventilatory drive via peripheral chemoreceptors. Administering high-flow oxygen eliminates this drive, reduces respiratory effort, and worsens hypoventilation — causing PaCO₂ to climb further. Additionally, the Haldane effect (oxygenated hemoglobin binds less CO₂) releases additional CO₂ into plasma, and relief of hypoxic pulmonary vasoconstriction redistributes blood flow to poorly ventilated lung units, increasing dead space. The somnolence represents worsening CO₂ narcosis. The appropriate strategy is controlled oxygen delivery via a Venturi mask targeting SpO₂ of 88–92%, with frequent ABG monitoring, and initiation of non-invasive ventilation (BiPAP) to augment alveolar ventilation if PaCO₂ continues to rise.

Question 5: CRITICAL THINKING

Explain why a large intrapulmonary right-to-left shunt causes hypoxemia that is refractory to supplemental oxygen, whereas V/Q mismatch-related hypoxemia generally responds well to oxygen therapy. In your answer, reference the oxygen-hemoglobin dissociation curve and the concept of venous admixture. Under what clinical circumstances might supplemental O₂ partially improve oxygenation even in the presence of a shunt?

Show answer

In V/Q mismatch, some lung units are underventilated relative to their perfusion (low V/Q), but they still receive some inspired gas. Supplemental oxygen raises the PAO₂ in these low-V/Q units enough to improve O₂ diffusion and restore adequate oxygen loading onto hemoglobin. Because the oxygen-hemoglobin dissociation curve is sigmoid-shaped, even modest increases in alveolar PO₂ in low-V/Q regions can shift those units onto the flat upper portion of the curve, substantially improving their saturation. In a true right-to-left shunt, however, blood completely bypasses ventilated alveoli — no amount of supplemental oxygen reaches the shunted blood. The well-ventilated units already operate on the flat upper portion of the dissociation curve at room air, so increasing their PAO₂ from 100 to 600 mmHg adds only a trivial amount of dissolved O₂ (following Henry's law) but cannot appreciably increase hemoglobin saturation beyond ~100%. When this fully saturated blood mixes with completely desaturated shunted blood (venous admixture), the resulting arterial PaO₂ remains low. That said, supplemental O₂ can provide modest benefit even with shunt if the shunt fraction is small (< 15–20%), because the small increment in dissolved oxygen and the prevention of low-V/Q contributions at the margins can partially offset the admixture. In clinical practice, refractory hypoxemia despite FiO₂ > 0.6 strongly suggests a shunt fraction exceeding 25–30%, at which point recruitment maneuvers, PEEP to open collapsed alveoli (converting shunt back into ventilated units), prone positioning, or ECMO become necessary.

SUMMARY

Lesson Summary

Summary

Hypoxemia (PaO₂ < 80 mmHg) and hypercapnia (PaCO₂ > 45 mmHg) represent two fundamentally different failures of respiratory function: oxygenation failure and ventilation failure, respectively. Hypoxemia arises from five mechanisms — low FiO₂, hypoventilation, V/Q mismatch, right-to-left shunt, and diffusion impairment — and is classified using the A-a gradient (normal gradient suggests hypoventilation or altitude; widened gradient points to parenchymal disease). Hypercapnia results from decreased central drive, neuromuscular pump failure, or increased dead space/CO₂ production, and is governed by the inverse relationship between alveolar ventilation and PaCO₂.

Clinically, Type I respiratory failure features isolated hypoxemia with normal or low PaCO₂ and is managed with supplemental O₂, PEEP, and treatment of the underlying cause. Type II respiratory failure features hypercapnia (usually with coexisting hypoxemia) and requires interventions to augment ventilation such as non-invasive positive-pressure ventilation or mechanical ventilation. The alveolar gas equation and A-a gradient are indispensable bedside tools for differentiating these conditions. A key clinical pitfall is over-oxygenating chronic CO₂ retainers, which can suppress the hypoxic ventilatory drive and worsen hypercapnia. Remember: pulse oximetry detects hypoxemia but is blind to hypercapnia — arterial blood gas analysis remains the gold standard.